Perseus A500 enables faster recovery from desflurane general anesthesia.


Journal

Journal of anesthesia
ISSN: 1438-8359
Titre abrégé: J Anesth
Pays: Japan
ID NLM: 8905667

Informations de publication

Date de publication:
04 2020
Historique:
received: 18 10 2019
accepted: 19 01 2020
pubmed: 6 2 2020
medline: 21 11 2020
entrez: 6 2 2020
Statut: ppublish

Résumé

The Dräger Perseus A500 (Perseus) anesthetic workstation has been designed with a lower internal volume. We evaluated the recovery time following general anesthesia using the Perseus workstation compared with that using the conventional Dräger Fabius Plus workstation. Following approval by our institutional research ethics committee, 50 patients receiving elective surgery under general anesthesia were enrolled in the study. Written informed consent was obtained from each patient. The patients were divided into the Perseus group and a control group. The Perseus anesthesia workstation was used for the Perseus group, and the Fabius Plus was used for the control group. General anesthesia was maintained with a 4.2% end-tidal concentration of desflurane, remifentanil, fentanyl, and regional anesthesia. After the surgical procedure, the administration of desflurane was discontinued. The inspiratory and expiratory desflurane concentration, time taken for patients to open their eyes, and the time taken to extubate the trachea after discontinuation of anesthetics were recorded. The inspiratory and expiratory desflurane concentration after the administration of desflurane was discontinued was lower in the Perseus group. Moreover, the time taken for patients to open their eyes was statistically significantly quicker in the Perseus group when compared with the control group: 284 ± 60 vs 325 ± 43 s, respectively. The time taken for extubation was also statistically significantly quicker in the Perseus group when compared with the control group: 350 ± 67 vs 388 ± 62 s, respectively. We demonstrate in this study that Perseus enables the faster wash-out of anesthetics and faster recovery of patients after general anesthesia.

Identifiants

pubmed: 32020373
doi: 10.1007/s00540-020-02740-8
pii: 10.1007/s00540-020-02740-8
doi:

Substances chimiques

Anesthetics, Inhalation 0
Anesthetics, Intravenous 0
Desflurane CRS35BZ94Q
Isoflurane CYS9AKD70P

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

281-285

Références

Br J Anaesth. 2005 Mar;94(3):306-17
pubmed: 15591326
J Anesth. 2006;20(4):268-73
pubmed: 17072690
Anesth Analg. 2009 Apr;108(4):1193-7
pubmed: 19299785
BMC Anesthesiol. 2017 Jan 19;17(1):10
pubmed: 28103806

Auteurs

Yasuhiro Morimoto (Y)

Department of Anesthesia, Ube Industries Central Hospital, 750 Nishikiwa, Ube, Yamaguchi, 755-0151, Japan. yasumorimo@gmail.com.

Hiroko Shiramoto (H)

Department of Anesthesia, Ube Industries Central Hospital, 750 Nishikiwa, Ube, Yamaguchi, 755-0151, Japan.

Yoko Shimamoto (Y)

Department of Anesthesia, Ube Industries Central Hospital, 750 Nishikiwa, Ube, Yamaguchi, 755-0151, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH